🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeremy Ryan

Dana-Farber Cancer Institute

ORCID: 0000-0002-3327-1283
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML”.

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Blood Advances(2024)10.1182/bloodadvances.2023012120
N/A
1.2DataRank · unranked
46 citations

Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey Cutler +18 more

Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2009506117
N/A
0DataRank · unranked
119 citations

Wen Zhou, Adrianna E. Amaro, James M. McFarland, Mariana Villalobos-Ortiz, Jeremy Ryan +7 more

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

Science Signaling(2020)10.1126/scisignal.aay1451
N/A
0DataRank · unranked
69 citations

Eman Y. Ahmed, Jennifer L. Guerriero, Ewa Sicińska, Emily Su, Elizaveta Lavrova +14 more

An Autochthonous Mouse Model of Myd88 - and BCL2 -Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-19-0059
N/A
0DataRank · unranked
38 citations

Tim Rehkämper, Pascal Nieper, Pauline Pfeiffer, Alessandra Holzem, Sebastian Klein +33 more

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1851
N/A
0DataRank · unranked
78 citations

Clément Larrue, Nastassja K. Scheidegger, Bo Kyung A. Seong, Neekesh V. Dharia, Miljan Kuljanin +17 more

Co-deletion of ATAD1 with PTEN primes cells for BIM-mediated apoptosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.01.450781
N/A
0DataRank · unranked
5 citations

Heidi L. Fresenius, Heather R. Keys, Corey N. Cunningham, Jeremy Ryan, Deepika Sirohi +9 more

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-021-00870-3
N/A
0DataRank · unranked
186 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more

Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction

eLife(2022)10.7554/elife.82860
N/A
0DataRank · unranked
20 citations

Heidi L. Fresenius, Corey N. Cunningham, Peng Wei, Heather R. Keys, Jordan A. Berg +12 more

BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics

Haematologica(2023)10.3324/haematol.2023.283060
N/A
0DataRank · unranked
6 citations

Youzhen Wang, Shumei Qiu, Mariana Villalobos-Ortiz, Jeremy Ryan, Erick Morris +3 more

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0001
N/A
0DataRank · unranked
11 citations

Karanpreet Singh Bhatia, Chuqi Wang, Marissa S. Pioso, Xiao Xian Lin, Ahmed M. Mamdouh +18 more

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.14.682414
N/A
0DataRank · unranked
0 citations

Leah Krotee, Jason Wu, Lindsey Thornton, Geoffrey Fell, Sonja Herter +19 more

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Cancer Cell(2020)10.1016/j.ccell.2020.10.010
N/A
0DataRank · unranked
177 citations

Marissa S. Pioso, Elyse A. Olesinski, Binyam Yilma, Jeremy Ryan, Thelma Mashaka +18 more

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

Blood Advances(2025)10.1182/bloodadvances.2025018631
N/A
0DataRank · unranked
0 citations

Haesook T. Kim, H. Moses Murdock, Anna Bosch, Kevin M. Panaro, Felicia Lim +20 more